118 related articles for article (PubMed ID: 2892935)
1. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
[TBL] [Abstract][Full Text] [Related]
3. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
[TBL] [Abstract][Full Text] [Related]
4. Studies on agents with vasodilator and beta-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665.
Seki T; Kanada A; Nakao T; Shiraiwa M; Asano H; Miyazawa K; Ishimori T; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):84-96. PubMed ID: 9468640
[TBL] [Abstract][Full Text] [Related]
5. Studies on agents with vasodilator and beta-blocking activities. IV.
Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
[TBL] [Abstract][Full Text] [Related]
6. Studies on agents with vasodilator and beta-blocking activities. I.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
[TBL] [Abstract][Full Text] [Related]
7. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
Demirayak S; Karaburun AC; Beis R
Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
Bansal R; Kumar D; Carron R; de la Calle C
Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
[TBL] [Abstract][Full Text] [Related]
9. SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.
Swayne GT; Owen DA; Taylor EM; Eden RJ; Slater RA; Howson W
Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):251-66. PubMed ID: 2892473
[TBL] [Abstract][Full Text] [Related]
10. Some pyridazinone and phthalazinone derivatives and their vasodilator activities.
Demirayak S; Karaburun AC; Kayagil I; Erol K; Sirmagul B
Arch Pharm Res; 2004 Jan; 27(1):13-8. PubMed ID: 14969331
[TBL] [Abstract][Full Text] [Related]
11. Studies on agents with vasodilator and beta-blocking activities. II.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
Owen DA; Eden RJ; Lamb MS; Taylor EM
J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
[TBL] [Abstract][Full Text] [Related]
13. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and antihypertensive activity of pyridazinone derivatives.
Siddiqui AA; Mishra R; Shaharyar M
Eur J Med Chem; 2010 Jun; 45(6):2283-90. PubMed ID: 20189270
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Kreighbaum WE; Matier WL; Dennis RD; Minielli JL; Deitchman D; Perhach JL; Comer WT
J Med Chem; 1980 Mar; 23(3):285-9. PubMed ID: 6102605
[TBL] [Abstract][Full Text] [Related]
16. 4,5-disubstituted pyridazin-3(2H)-ones as hypotensive drugs: incorporation of a beta-blocking moiety.
Gómez-Gil MC; Gómez-Parra V; Sánchez F; Torres T
Arch Pharm (Weinheim); 1986 Jan; 319(1):60-4. PubMed ID: 2870697
[No Abstract] [Full Text] [Related]
17. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
[TBL] [Abstract][Full Text] [Related]
19. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
Baldwin JJ; Hirschmann R; Lumma PK; Lumma WC; Ponticello GS; Sweet CS; Scriabine A
J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
[TBL] [Abstract][Full Text] [Related]
20. 6-(Substituted phenyl)-5-substituted-4,5-dihydro-3(2H)-pyridazinones. Antihypertensive agents.
McEvoy FJ; Allen GR
J Med Chem; 1974 Mar; 17(3):281-6. PubMed ID: 4811221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
